pharma-company /Medicinal products /Active ingredients

Rx · PZN 02592660, 02593205

PENTASA 500 mg prolonged-release tablets B

German trade namePENTASA 500 mg Retardtabletten B

Active ingredientMesalazineSubstance (DE)MesalazinPharmaceutical formProlonged-release tablets

According to the data available to us: no longer marketed

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Average purchase price (B2B)

~ €58

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for PENTASA 500 mg prolonged-release tablets B.

Review purchasing terms

PENTASA 500 mg prolonged-release tablets B contains the active ingredient Mesalazine (German Mesalazin) and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
025926600.00.0~ €29
025932050.00.0~ €86

According to the data available to us, PENTASA 500 mg prolonged-release tablets B is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.